Investigational Drug Information for Bevirimat
✉ Email this page to a colleague
What is the development status for investigational drug Bevirimat?
Bevirimat is an investigational drug.
There have been 3 clinical trials for Bevirimat.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2006.
The most common disease conditions in clinical trials are HIV Infections, Infections, and Infection. The leading clinical trial sponsors are Myrexis Inc. and [disabled in preview].
Summary for Bevirimat
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 564 |
| WIPO Patent Applications | 331 |
| Japanese Patent Applications | 116 |
| Clinical Trial Progress | Phase 2 (2006-04-01) |
| Vendors | 0 |
Recent Clinical Trials for Bevirimat
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days | Myrexis Inc. | Phase 2 |
| Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection. | Myrexis Inc. | Phase 2 |
| Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks* | Myrexis Inc. | Phase 2 |
Clinical Trial Summary for Bevirimat
Top disease conditions for Bevirimat
Top clinical trial sponsors for Bevirimat
US Patents for Bevirimat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
